CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- 8-K Event Executive or director change
- 4 Shares withheld for taxes Interim President and CEO gave up 3,223 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 21,283 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,417 shares (to pay taxes)
- 4 Open-market buy Director bought 14,500 shares at an average $1.24 ($17,955)
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Scientific Officer gave up 2,583 shares (to pay taxes)
Page 10 of 44 · 872 filings